These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8092154)

  • 41. [The drug commission of German physicians and phase IV screening].
    Ochsenfahrt H
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):929-32. PubMed ID: 6417498
    [No Abstract]   [Full Text] [Related]  

  • 42. The investigational drug steering committee.
    Ratain MJ
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):779-80. PubMed ID: 17998895
    [No Abstract]   [Full Text] [Related]  

  • 43. [Drug committees in Denmark. Status and future challenges].
    Rabøl R; Kampmann JP; Christensen HR
    Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009
    [No Abstract]   [Full Text] [Related]  

  • 44. Correct utilization and management of peripherally inserted central catheters and midline catheters in the alternate care setting.
    Carlson KR
    J Intraven Nurs; 1999; 22(6 Suppl):S46-50. PubMed ID: 10865608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient drug safety requires P and T attention to these guidelines.
    Myers RS
    Mod Hosp; 1968 Nov; 111(5):104 passim. PubMed ID: 5712126
    [No Abstract]   [Full Text] [Related]  

  • 46. [Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].
    Müller-Oerlinghausen B
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):606-10. PubMed ID: 9527451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The peripheral intravenous catheter: an appropriate yet often overlooked choice for venous access.
    Gorski LA
    Home Healthc Nurse; 2009 Feb; 27(2):130-2. PubMed ID: 19212229
    [No Abstract]   [Full Text] [Related]  

  • 48. Questions raised regarding double blind comparison research.
    Toth LA; Robertson J
    Pediatr Nurs; 1996; 22(1):80, 79. PubMed ID: 8700633
    [No Abstract]   [Full Text] [Related]  

  • 49. [Detection and prevention of drug-induced lesions. 20 years' experiences in the Drug Committee of the German Medical Society].
    Homann G
    Internist (Berl); 1973 Jan; 14(1):19-24. PubMed ID: 4576792
    [No Abstract]   [Full Text] [Related]  

  • 50. Development of ASHP therapeutic guidelines.
    Dotson LR; Witmer DR
    Am J Health Syst Pharm; 1995 Feb; 52(3):254-5. PubMed ID: 7749951
    [No Abstract]   [Full Text] [Related]  

  • 51. The formulary system revisited.
    Lantos RL
    Hosp Formul; 1979 Jun; 14(6):664, 662. PubMed ID: 10297481
    [No Abstract]   [Full Text] [Related]  

  • 52. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developing guidelines for biotechnology drug use: experience with antithrombin III.
    Romac DR; Poole P; Owings JT; Mahackian K; Foulke G; Tharratt RS; Albertson TE
    Formulary; 1995 Sep; 30(9):520-3, 525-7, 531. PubMed ID: 10151737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Not for the pharmaceutical institute: Stake on clinical pharmacology. Regional rationalization is profitable].
    Lakartidningen; 1970 Jan; 67(5):483-6. PubMed ID: 5426359
    [No Abstract]   [Full Text] [Related]  

  • 55. Comment on ASHP therapeutic guidelines.
    Wood WA
    Clin Pharm; 1993 Jun; 12(6):399. PubMed ID: 8267760
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug supply report and expert pronouncement].
    Rosén A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469312
    [No Abstract]   [Full Text] [Related]  

  • 57. [Create or strengthen the drug committee at a hospital].
    Bruneton C
    Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ASHP national survey of hospital-based pharmaceutical services--1992.
    Crawford SY; Myers CE
    Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Work of the committee on drug side effects].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1237-8. PubMed ID: 1162664
    [No Abstract]   [Full Text] [Related]  

  • 60. [Registration of adverse effects in drug therapy].
    Skobba TJ
    Tidsskr Nor Laegeforen; 1970 Jan; 90(1):6-9. PubMed ID: 5426192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.